CUPERTINO, Calif., Sept. 7, 2010 (GLOBE NEWSWIRE) -- DURECT Corporation (Nasdaq:DRRX) announced today that management is scheduled to present at three upcoming healthcare conferences.
- Joe Stauffer, Chief Medical Officer and EVP-Corporate Strategy, will deliver a talk entitled "FDA Regulations and Testing for Pain Products" at the National Conference on Pain for Frontline Practitioners in Las Vegas, Nevada on Wednesday, September 8 at 2:30 p.m. Pacific Time.
- Matt Hogan, Chief Financial Officer, will present at the Rodman & Renshaw Life Sciences Conference in New York on Tuesday, September 14 at 10:50 a.m. Eastern Time. A live audio webcast of the presentation will be available by accessing http://www.wsw.com/webcast/rrshq18/drrx .
- Matt Hogan will also present at the UBS Global Life Sciences Conference in New York on Monday, September 20 at 8:00 a.m. Eastern Time. A live audio webcast of the presentation will be available by accessing DURECT's homepage at http://www.durect.com and clicking "Investor Relations." If you are unable to participate during the live webcast, the call will be archived on DURECT's website under Audio Archive in the "Investor Relations" section.
CONTACT: DURECT Corporation Matthew J. Hogan, Chief Financial Officer 408-777-4936